Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Ivermectin is a macrolide antiparasitic drug characterized by a 16-membered macrocyclic lactone ring structure, widely recognized for its broad-spectrum antiparasitic activity and low toxicity. Developed by Satoshi Omura and William C. Campbell, who were awarded the Nobel Prize in Physiology or Medicine in 2015 for its discovery, ivermectin has been instrumental in treating various parasitic diseases such as river blindness, elephantiasis, and scabies. Its mechanism of action involves binding to glutamate-gated chloride channels in nerve and muscle cells of parasites, leading to paralysis and death of the parasite. Recent research has explored its potential anticancer properties and the synthesis of novel ivermectin derivatives, highlighting its multifaceted therapeutic applications beyond its traditional use in parasitology.
仅用于科研。不用于诊断过程。未经明确授权不得转售。